Literature DB >> 31992085

Marine bacteria as source of antimicrobial compounds.

Paolo Stincone1, Adriano Brandelli1.   

Abstract

The marine environment encompasses a huge biological diversity and can be considered as an underexplored location for prospecting bioactive molecules. In this review, the current state of art about antimicrobial molecules from marine bacteria has been summarized considering the main phylum and sources evolved in a marine environment. Considering the last two decades, we have found as most studied group of bacteria producers of substances with antimicrobial activity is the Firmicutes phylum, in particular strains of the Bacillus genus. The reason for that can be attributed to the difficult cultivation of typical Actinobacteria from a marine sediment, whose members are the major producers of antimicrobial substances in land environments. However, a reversed trend has been observed in recent years with an increasing number of reports settling on Actinobacteria. Great diversity of chemical structures have been identified, such as fijimicyns and lynamicyns from Actinomycetes and macrolactins produced by Bacillus.

Keywords:  Antibiotic; antimicrobial; bioactive compounds; fijimycins; macrolactins; marine bacteria; marine biology

Year:  2020        PMID: 31992085     DOI: 10.1080/07388551.2019.1710457

Source DB:  PubMed          Journal:  Crit Rev Biotechnol        ISSN: 0738-8551            Impact factor:   8.429


  16 in total

1.  The Distribution and Antibacterial Activity of Marine Sponge-Associated Bacteria in the Aegean Sea and the Sea of Marmara, Turkey.

Authors:  Gülşen Altuğ; Pelin S Çiftçi Türetken; Samet Kalkan; Bülent Topaloğlu
Journal:  Curr Microbiol       Date:  2021-04-30       Impact factor: 2.188

2.  Burkholderia gladioli MB39 an Antarctic Strain as a Biocontrol Agent.

Authors:  Dinorah A Sarli; Leandro A Sánchez; Osvaldo D Delgado
Journal:  Curr Microbiol       Date:  2021-04-27       Impact factor: 2.188

3.  Oceanisphaera pacifica sp. nov., isolated from the intestine of Trichiurus japonicus.

Authors:  Jian-Heng Xue; Li-Fang Shi; Bei-Ning Zhang; Wen-Jie Wu; Yuan Gao; Qian Zhu; Li-Hua Zhao
Journal:  Arch Microbiol       Date:  2022-05-19       Impact factor: 2.552

Review 4.  Cyanobacterial secondary metabolites towards improved commercial significance through multiomics approaches.

Authors:  Shaloo Verma; Shobit Thapa; Nahid Siddiqui; Hillol Chakdar
Journal:  World J Microbiol Biotechnol       Date:  2022-04-29       Impact factor: 3.312

Review 5.  Marine Cyclic Peptides: Antimicrobial Activity and Synthetic Strategies.

Authors:  Ricardo Ribeiro; Eugénia Pinto; Carla Fernandes; Emília Sousa
Journal:  Mar Drugs       Date:  2022-06-15       Impact factor: 6.085

Review 6.  Marine Microbial-Derived Antibiotics and Biosurfactants as Potential New Agents against Catheter-Associated Urinary Tract Infections.

Authors:  Shuai Zhang; Xinjin Liang; Geoffrey Michael Gadd; Qi Zhao
Journal:  Mar Drugs       Date:  2021-04-29       Impact factor: 5.118

Review 7.  Actinomycetes: A Never-Ending Source of Bioactive Compounds-An Overview on Antibiotics Production.

Authors:  Davide De Simeis; Stefano Serra
Journal:  Antibiotics (Basel)       Date:  2021-04-22

8.  Mersaquinone, A New Tetracene Derivative from the Marine-Derived Streptomyces sp. EG1 Exhibiting Activity against Methicillin-Resistant Staphylococcus aureus (MRSA).

Authors:  Min Cheol Kim; Reiko Cullum; Ali M S Hebishy; Hala A Mohamed; Ahmed H I Faraag; Nehad M Salah; Mohamed S Abdelfattah; William Fenical
Journal:  Antibiotics (Basel)       Date:  2020-05-14

Review 9.  Alimentary and Pharmaceutical Approach to Natural Antimicrobials against Clostridioides difficile Gastrointestinal Infection.

Authors:  Miguel Tortajada-Girbés; Alejandro Rivas; Manuel Hernández; Ana González; Maria A Ferrús; Maria C Pina-Pérez
Journal:  Foods       Date:  2021-05-19

Review 10.  Microbial single-cell omics: the crux of the matter.

Authors:  Anne-Kristin Kaster; Morgan S Sobol
Journal:  Appl Microbiol Biotechnol       Date:  2020-08-26       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.